ACAD vs. ABBV
Compare and contrast key facts about ACADIA Pharmaceuticals Inc. (ACAD) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ACAD or ABBV.
Correlation
The correlation between ACAD and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ACAD vs. ABBV - Performance Comparison
Key characteristics
ACAD:
-0.02
ABBV:
0.73
ACAD:
0.33
ABBV:
0.99
ACAD:
1.04
ABBV:
1.15
ACAD:
-0.01
ABBV:
0.88
ACAD:
-0.03
ABBV:
2.15
ACAD:
15.42%
ABBV:
8.44%
ACAD:
47.43%
ABBV:
27.49%
ACAD:
-96.29%
ABBV:
-45.09%
ACAD:
-70.30%
ABBV:
-13.55%
Fundamentals
ACAD:
$2.53B
ABBV:
$351.09B
ACAD:
$1.36
ABBV:
$2.34
ACAD:
11.13
ABBV:
84.82
ACAD:
-0.42
ABBV:
0.42
ACAD:
2.64
ABBV:
6.05
ACAD:
3.39
ABBV:
105.59
ACAD:
$751.97M
ABBV:
$57.37B
ACAD:
$693.08M
ABBV:
$44.44B
ACAD:
$76.85M
ABBV:
$16.33B
Returns By Period
In the year-to-date period, ACAD achieves a -7.74% return, which is significantly lower than ABBV's 6.39% return. Over the past 10 years, ACAD has underperformed ABBV with an annualized return of -7.88%, while ABBV has yielded a comparatively higher 15.79% annualized return.
ACAD
-7.74%
20.07%
-1.57%
-1.17%
-19.76%
-7.88%
ABBV
6.39%
6.62%
-5.71%
19.87%
22.17%
15.79%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ACAD vs. ABBV — Risk-Adjusted Performance Rank
ACAD
ABBV
ACAD vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ACADIA Pharmaceuticals Inc. (ACAD) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ACAD vs. ABBV - Dividend Comparison
ACAD has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.44%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACAD ACADIA Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ABBV AbbVie Inc. | 3.44% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
ACAD vs. ABBV - Drawdown Comparison
The maximum ACAD drawdown since its inception was -96.29%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ACAD and ABBV. For additional features, visit the drawdowns tool.
Volatility
ACAD vs. ABBV - Volatility Comparison
ACADIA Pharmaceuticals Inc. (ACAD) has a higher volatility of 17.75% compared to AbbVie Inc. (ABBV) at 10.10%. This indicates that ACAD's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ACAD vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between ACADIA Pharmaceuticals Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ACAD vs. ABBV - Profitability Comparison
ACAD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, ACADIA Pharmaceuticals Inc. reported a gross profit of 237.80M and revenue of 259.60M. Therefore, the gross margin over that period was 91.6%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
ACAD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, ACADIA Pharmaceuticals Inc. reported an operating income of 153.50M and revenue of 259.60M, resulting in an operating margin of 59.1%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
ACAD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, ACADIA Pharmaceuticals Inc. reported a net income of 143.74M and revenue of 259.60M, resulting in a net margin of 55.4%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.